PRS6 A Model for Determining the Budget Impact of Introducing a New Single-Inhaler Triple Combination Therapy for Managing Moderate to Very Severe COPD in the United States
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI